As of April 2024 Strides Pharma has a market cap of $0.96 Billion. This makes Strides Pharma the world's 5165th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.96 B | 34.75% |
2023 | $0.71 B | 87.86% |
2022 | $0.38 B | -29.19% |
2021 | $0.53 B | -49.9% |
2020 | $1.07 B | 136.8% |
2019 | $0.45 B | -23.01% |
2018 | $0.59 B | -48.65% |
2017 | $1.14 B | -17.7% |
2016 | $1.39 B | 20.76% |
2015 | $1.15 B | 28.22% |
2014 | $0.90 B | 163.16% |
2013 | $0.34 B | -70.87% |
2012 | $1.17 B | 166.34% |
2011 | $0.44 B | -23.56% |
2010 | $0.57 B | 178.96% |
2009 | $0.20 B | 178.35% |
2008 | $74.45 M | -70.56% |
2007 | $0.25 B | -13.12% |
2006 | $0.29 B | 21.24% |
2005 | $0.24 B |
On Apr 25th, 2024 the market cap of Strides Pharma was reported to be: